Search
Benitec Biopharma Inc
BNTCAdd to Watchlist
9.640USD
-0.190-1.93%
Close 09-24 16:00（ET）
331.13MMarket Cap
LossP/E TTM
Benitec Biopharma Inc (BNTC) Revenue Performance
Updated: Jun 30, 2023Last year, Benitec Biopharma Inc generated 75.00K USD for its biggest-performing segment, Licensing revenue. The Australia made the largest contribution, accounting for 10.46M USD last year.
By Business
Revenue
Proportion
Annual
Annual
Quarterly
Licensing revenue
Service revenue
Royalty revenue
FY2023
FY2022
FY2021
Licensing revenue
75.00K(100.00%)
73.00K(100.00%)
59.00K(100.00%)
Service revenue
--(--)
--(--)
--(--)
Royalty revenue
--(--)
--(--)
--(--)
By Region
Revenue
Proportion
Annual
Annual
Quarterly
Australia
United States
FY2019
Australia
10.46M(100.00%)
United States
--(--)